Gastroenterology and Hepatology, Veterans Affairs Medical Center, Kansas City, Missouri 64128-2295, USA.
Gut. 2012 Mar;61(3):402-8. doi: 10.1136/gutjnl-2011-300187. Epub 2011 Oct 13.
Cap-assisted colonoscopy (CAC) uses a small plastic transparent cap attached to the tip of the colonoscope that can depress and flatten colonic folds and thus improve visualisation of their proximal aspects. The aim of this study was to compare CAC with standard colonoscopy (SC; high-definition white light) for adenoma detection rates.
This is a prospective randomised controlled trial.
The study was performed in a tertiary-care Veterans Affairs Medical Center in the USA.
Subjects undergoing screening or surveillance colonoscopy were enrolled.
Subjects were randomised to undergo either CAC or SC.
The outcome measures were the proportion of subjects with at least one adenoma, the number of adenomas detected per subject, insertion time, caecal intubation rates and complications.
420 subjects were enrolled and included in the study (210 in each group). The proportion of subjects with at least one adenoma was higher with CAC compared to SC (69% vs 56%, p=0.009). CAC also detected a higher number of adenomas per subject (2.3 vs 1.4, p<0.001). The caecal intubation time was shorter with CAC (3.29 min vs 3.98 min, p<0.001). The caecal intubation rates were similar in the two groups (99% vs 98%, p=0.37). There were no complications associated with CAC or SC.
CAC detected a 13% higher number of subjects with at least one adenoma and 59% higher adenomas per subject. CAC is a safe, effective and practical means to improve adenoma detection rates.
NCT 01211132.
帽辅助结肠镜检查(CAC)使用附在结肠镜尖端的小塑料透明帽,可以压平和展平结肠褶皱,从而改善其近端的可视化效果。本研究的目的是比较 CAC 与标准结肠镜检查(SC;高清白光)在腺瘤检出率方面的差异。
这是一项前瞻性随机对照试验。
该研究在美国一家三级保健退伍军人事务医疗中心进行。
接受筛查或监测结肠镜检查的患者入组。
患者被随机分配接受 CAC 或 SC。
主要观察指标为至少有一个腺瘤的患者比例、每个患者检出的腺瘤数量、插入时间、盲肠插管率和并发症。
420 名患者入组并纳入研究(每组 210 名)。与 SC 相比,CAC 组有更多的患者至少有一个腺瘤(69%比 56%,p=0.009)。CAC 还检测到每个患者更多的腺瘤(2.3 比 1.4,p<0.001)。CAC 的盲肠插管时间更短(3.29 分钟比 3.98 分钟,p<0.001)。两组的盲肠插管率相似(99%比 98%,p=0.37)。CAC 或 SC 均无相关并发症。
CAC 检测到至少有一个腺瘤的患者比例增加了 13%,每个患者的腺瘤数量增加了 59%。CAC 是一种安全、有效且实用的方法,可以提高腺瘤检出率。
NCT 01211132。